Bank of Montreal’s Arcadia Biosciences RKDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-751
Closed -$164K 4604
2019
Q4
$164K Sell
751
-250
-25% -$50.2K ﹤0.01% 3269
2019
Q3
$187K Hold
1,001
﹤0.01% 2954
2019
Q2
$123K Hold
1,001
﹤0.01% 3217
2019
Q1
$280K Hold
1,001
﹤0.01% 2562
2018
Q4
$127K Sell
1,001
-375
-27% -$63K ﹤0.01% 2822
2018
Q3
$269K Hold
1,376
﹤0.01% 2606
2018
Q2
$454K Buy
1,376
+1,126
+450% +$615K ﹤0.01% 2382
2018
Q1
$240K Buy
+250
New +$112K ﹤0.01% 2550

Other funds holding RKDA

Bank of Montreal's RKDA Position: Q1 2020 in Review

Bank of Montreal sold out of Arcadia Biosciences (RKDA) in Q1 2020, closing a stake of 751 shares — an estimated $164K sold.

Bank of Montreal first reported a position in RKDA in Q1 2018 and held it in 8 quarters. The position peaked at $454K in Q2 2018. 12 funds tracked by Wall St. Rank hold RKDA as of Q1 2020.

  • Bank of Montreal reported no remaining Arcadia Biosciences position as of Q1 2020 after selling out during the quarter.
  • Bank of Montreal sold 751 Arcadia Biosciences shares in Q1 2020, an estimated $164K.
  • Bank of Montreal first reported a position in Arcadia Biosciences in Q1 2018 and held it in 8 quarters.
  • Bank of Montreal's Arcadia Biosciences position peaked at $454K in Q2 2018.
  • 12 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2020.

Based on Bank of Montreal's 13F filing for Q1 2020, filed 13 May 2020.